SUNPURE EXTRACTS PVT LTD

Overview

SUNPURE EXTRACTS PVT LTD is an active pharmaceutical ingredient (API) supplier with 21 active FDA Type II Drug Master Files, covering ANDROGRAPHIS PANICULATA DRY EXTRACT; ASHWAGANDHA EXTRACT POWDER; BANABA EXTRACT 18%; BERBERINE HYDROCHLORIDE EXTRACT 95%; BOSWELLIA SERRATA EXTRACT (AKBA-30o/o); CAFFEINE ANHYDROUS (NATURAL) 99%.

API / Drug Master Files

SUNPURE EXTRACTS PVT LTD holds 21 active (21 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PTEROCARPUS MARSUPIUM EXTRACT 90%Active2025-08-02
• CENTELLA ASIATICA EXTRACT (ASIATICOSIDE 95%)Active2025-07-02
• CENTELLA SELECTED EXTRACT TRITERPENES (TECA) 95%Active2025-07-02
• PONGAMOL EXTRACT 95%Active2025-07-02
• CENTELLA ASIATICA EXTRACT 95% (MADECASSOSIDE)Active2024-08-22
• COLEUS FORSKOHLII EXTRACT 98%Active2023-11-20
• BERBERINE HYDROCHLORIDE EXTRACT 95%Active2023-07-05
• FENUGREEK EXTRACT 50% (FENUTEIN)Active2022-12-21
• BANABA EXTRACT 18%Active2022-12-21
• CAFFEINE ANHYDROUS (NATURAL) 99%Active2021-12-14
• ANDROGRAPHIS PANICULATA DRY EXTRACTActive2021-11-18
• CALCIUM SENNOSIDE 60% (SENNA 60%)Active2021-11-18
• CURCUMIN EXTRACT 95%Active2021-05-18
• LUTEIN POWDER 20% (ZEAXANTHIN 4%)Active2021-05-18
• MONOAMMONIUM GLYCYRRHIZINATEActive2020-11-10

Showing 15 of 21 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SUNPURE EXTRACTS PVT LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.